MedTrace Logo

Russian National Registry of LAAO

NCT04322474 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2020-03-26

No results posted yet for this study

Summary

The first Russian registry presents data from two hundred consecutive patients with nonvalvular atrial fibrillation, who undergone left atrial appendage occlusion (LAAO) using the Watchman device and the Amplatzer cardiac plug. This government-funded catheter-based LAAO program was started in September 2015 and was completed in December 2017. Data collection was finished in December 2018. Five clinics agreed to participate in the study.

Patients' baseline characteristics, procedure, and follow up data were collected according to established registry protocol. Patients were followed at 45 days, 3, 6 and 12 months after enrollment. At each follow-up visit, the data regarding clinical events and healthcare utilization was collected.

Conditions

Interventions

DEVICE

Catheter-based left atrial appendage occlusion

Catheter-based implantation of left atrial appendage occluder

Sponsors & Collaborators

  • National Research Center for Preventive Medicine

    lead OTHER_GOV

Principal Investigators

  • Karapet Davtyan, PhD · National Research Center for Preventive Medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-01
Primary Completion
2017-12-30
Completion
2018-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04322474 on ClinicalTrials.gov